Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0363220080460060862
Korean Journal of Dermatology
2008 Volume.46 No. 6 p.862 ~ p.865
Two Cases of Acneiform Eruption Caused by Epidermal Growth Factor Receptor Inhibitors
Choi Gyu-Won

Lee Chae-Young
Lee Yeong-Kyu
Kim Hong-Seok
Kim Ki-Ho
Kim Young-Hun
Abstract
Epidermal growth factor receptor (EGFR) inhibitors are associated with unique and dramatical dermatological side effects. The most commonly encountered adverse effect is a mild skin toxicity characterized by a sterile follicular and pustular rash that may be treated empirically and usually does not require treatment modification. Secondary adverse reactions seen with anti-EGFR therapy include xerosis, pruritus, paronychia, hair abnormality, and mucositis. According to the Korean literature, there are no reports of acneiform eruption induced by erlotinib (Tarceva¨Þ). We report a case of acneiform eruption induced by cetuximab (Erbitux¨Þ) and a case of acneiform eruption induced by erlotinib (Tarceva¨Þ). (Korean J Dermatol 2008;46(6):862¡­865)
KEYWORD
Cetuximab, Epidermal growth factor receptor inhibitor, Erlotinib
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø